These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
613 related items for PubMed ID: 2564677
21. Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells. Katz JD, Nishanian P, Mitsuyasu R, Bonavida B. J Clin Immunol; 1988 Nov; 8(6):453-8. PubMed ID: 2975670 [Abstract] [Full Text] [Related]
24. Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus. Cooper DA, Tindall B, Wilson EJ, Imrie AA, Penny R. J Infect Dis; 1988 May; 157(5):889-96. PubMed ID: 2966211 [Abstract] [Full Text] [Related]
25. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Oyaizu N, Chirmule N, Kalyanaraman VS, Hall WW, Pahwa R, Shuster M, Pahwa S. Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2379-83. PubMed ID: 2315327 [Abstract] [Full Text] [Related]
26. AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules. Dudhane A, Wang ZQ, Orlikowsky T, Gupta A, Wormser GP, Horowitz H, Kufer P, Hoffmann MK. AIDS Res Hum Retroviruses; 1996 Jul 01; 12(10):893-9. PubMed ID: 8798974 [Abstract] [Full Text] [Related]
27. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Lyerly HK, Matthews TJ, Langlois AJ, Bolognesi DP, Weinhold KJ. Proc Natl Acad Sci U S A; 1987 Jul 01; 84(13):4601-5. PubMed ID: 3037522 [Abstract] [Full Text] [Related]
28. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones. Fidler SJ, Dorrell L, Ball S, Lombardi G, Weber J, Hawrylowicz C, Rees AD. Immunology; 1996 Sep 01; 89(1):46-53. PubMed ID: 8911139 [Abstract] [Full Text] [Related]
29. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Gruters RA, Terpstra FG, De Jong R, Van Noesel CJ, Van Lier RA, Miedema F. Eur J Immunol; 1990 May 01; 20(5):1039-44. PubMed ID: 2162775 [Abstract] [Full Text] [Related]
31. Functional dichotomy of CD4+ T helper lymphocytes in asymptomatic human immunodeficiency virus infection. Clerici M, Via CS, Lucey DR, Roilides E, Pizzo PA, Shearer GM. Eur J Immunol; 1991 Mar 01; 21(3):665-70. PubMed ID: 1672645 [Abstract] [Full Text] [Related]
36. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. Groux H, Torpier G, Monté D, Mouton Y, Capron A, Ameisen JC. J Exp Med; 1992 Feb 01; 175(2):331-40. PubMed ID: 1346269 [Abstract] [Full Text] [Related]
37. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, de Wolf F, Al BJ, Roos M, Lange JM, Danner SA, Goudsmit J. J Clin Invest; 1988 Dec 01; 82(6):1908-14. PubMed ID: 2974045 [Abstract] [Full Text] [Related]